Task: Answer the multiple-choice question.
Query: Which drug exhibits a 3.652% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a O=C(Nc1ccncc1)c1cccc(F)c1
b CC(C)CC(NC(=O)C(NC(=O)OC(C)(C)C)C(C)C)C(N)=O
c COc1ccc(Cl)cc1C(=O)NC(=S)Nc1nc(C)cc(C)n1
Answer: c. COc1ccc(Cl)cc1C(=O)NC(=S)Nc1nc(C)cc(C)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(Cl)cc1C(=O)NC(=S)Nc1nc(C)cc(C)n1
COc1ccc(Cl)cc1C(=O)NC(=S)Nc1nc(C)cc(C)n1
5-chloro-N-[(4,6-dimethylpyrimidin-2-yl)carbamothioyl]-2-methoxybenzamide